Gene transfer in the kidney

American Journal of Physiology - Renal Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Kelley, Vicki Rubin ^a,b   Sukhatme, Vikas P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Somatic gene transfer

Indexed keywords

VIRUS VECTOR;

AUTOIMMUNE DISEASE; CLONING VECTOR; GENE TRANSFER; GLOMERULOPATHY; HUMAN; KIDNEY CANCER; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TARGET ORGAN;

EID: 0032943648     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.276.1.f1     Document Type: Review

References (72)

1. Ali, M., R. Lemoine, and J. A. Ring. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1: 367-384, 1994.
2. Anderson, W. F. Human gene therapy. Nature 392, Suppl.: 25-30, 1998.
3. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632, 1995.
4. Boletta, A., A. Benigni, J. Lutz, G. Remuzzi, M. R. Soria, and L. Monaco. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8: 1243-1251, 1997.
5. Bosch, R. J., A. S. Woolf, and L. G. Fine. Gene transfer into the mammalian kidney: direct retrovirus transduction of regenerating tubular epithelial cells. Exp. Nephrol. 1: 49-54, 1993.
6. Chen, H. H., L. M. Mack, R. Kelly, M. Ontell, S. Kochanek, and P. R. Clemens. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA 94: 1645-1650, 1997.
7. Consortium on TEPKD. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894, 1994.
8. Consortium on TIPKD. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
9. Cowley, B. D. J. Autosomal dominant polycystic kidney disease in the rat. Kidney Int. 43: 522-534, 1993.
10. Crystal, R. G. Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404-410, 1995.
11. Danos, O., and R. Mulligan. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85: 6460-6464, 1988.
12. Dedieu, J.-F., E. Vigne, C. Torrent, C. Jullien, I. Mahfouz, J. M. Caillaud, N. Aubailly, C. Orsini, J. M. Guillaume, P. Opolon, P. Delaere, M. Perricaudet, and P. Yeh. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71: 4626-4637, 1997.
13. Descamps, V., N. Blumenfeld, J.-L. Villeval, W. Vainchenker, M. Perricaudet, and Y. Beuzard. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum. Gene Ther. 5: 979-985, 1994.
14. Fine, L. G. Gene transfer into the kidney: promise for unraveling disease mechanisms, limitations for human gene therapy. Kidney Int. 49: 612-619, 1996.
15. Haecker, S. E., H. H. Stedman, R. J. Balice-Gordon, D. B. Smith, J. P. Greelish, M. A. Mitchell, A. Wells, H. L. Sweeney, and J. M. Wilson. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum. Gene Ther. 7: 1907-1914, 1996.
16. Hamamori, Y., B. Samal, J. Tian, and L. Kedes. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95: 1808-1813, 1995.
17. Heikkila, P., T. Parpala, O. Lukkarinen, M. Weber, and K. Tryggvason. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system: first step towards gene therapy of Alport syndrome. Gene Ther. 3: 21-27, 1996.
18. Isaka, Y., D. K. Brees, K. Ikegaya, E. Imai, N. A. Noble, and W. A. Border. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2: 418-423, 1996.
19. Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92: 2597-2601, 1993.
20. Itoh, N., A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, S. Nagata, N. Kono, and Y. Matsuzawa. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186: 613-618, 1997.
21. Kaneda, Y., K. Iwai, and T. Uchida. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378, 1989.
22. Kang, S. M., A. Hoffmann, D. Le, M. L. Springer, P. G. Stock, and H. M. Blau. Immune response and myoblasts that express Fas ligand. Science 278: 1322-1324, 1997.
23. Kang, S. M., D. B. Schneider, Z. Lin, D. Hanahan, D. A. Dichek, P. G. Stock, and S. Baekkeskov. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. 3: 738-743, 1997.
24. Kaplan, J. M., D. Armentano, T. E. Sparer, S. G. Wynn, P. A. Peterson, S. C. Wadsworth, K. K. Couture, S. E. Pennington, J. A. St. George, L. R. Gooding, and A. E. Smith. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8: 45-56, 1997.
25. Kaspareit-Rittinghausen, J., F. Deerberg, and A. Wcislo. Adult polycystic kidney disease associated with renal hypertension, renal osteodystrophy, and uremic enteritis in SPRD rats. Am. J. Pathol. 139: 693-696, 1991.
26. Kaspareit-Rittinghausen, J., K. Rapp, F. Deerberg, A. Wcislo, and C. Messow. Hereditary polycystic kidney disease associated with osteorenal syndrome in rats. Vet. Pathol. 26: 195-201, 1989.
27. Kitamura, M. Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc. Natl. Acad. Sci. USA 93: 7387-7391, 1996.
28. Kitamura, M. Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J. Clin. Invest. 94: 497-505, 1994.
29. Kitamura, M., S. Burton, H. J. English, H. Kawach, and L. G. Fine. Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int. 48: 1747-1757, 1995.
30. Kitamura, M., S. Burton, T. Yokoo, and L. G. Fine. Gene delivery into the renal glomerulus by transfer of genetically engineered, autologous mesangial cells. Exp. Nephrol. 4: 56-59, 1994.
31. Kitamura, M., and L. G. Fine. Gene transfer into the kidney: promises and limitations. Kidney Int. Suppl. 60: S86-S90, 1997.
32. Kitamura, M., and H. Kqwachi. Creation of an in vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity. J. Clin. Invest. 100: 1394-1399, 1997.
33. Knechtle, S. J., J. Wang, S. Jiao, E. K. Geissler, R. Sumimoto, and J. Wolff. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 57: 990-996, 1994.
34. Kochanek, S., P. R. Clemens, K. Mitani, H.-H. Chen, S. Chan, and C. T. Caskey. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93: 5731-5736, 1996.
35. Lai, L. W., D. M. Chan, R. P. Erickson, S. J. Hsu, and Y. H. Lien. Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J. Clin. Invest. 101: 1320-1325, 1998.
36. Lai, L. W., G. W. Moeckel, and Y. H. Lien. Kidney-targeted liposome-mediated gene transfer in mice. Gene Ther. 4: 426-431, 1997.
37. Langer, R. Drug delivery and targeting. Nature 392, Suppl.: 5-10, 1998.
38. Lau, H. T., M. Yu, A. Fontana, and C. J. J. Stoeckert. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273: 109-112, 1996.
39. Lein, Y. H., and L. W. Lai. Gene therapy for renal diseases. Kidney Int. Suppl. 61: S85-S88, 1997.
40. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. Long-term survival of xenogenetic pancreatic islet grafts induced by CTLA4Ig. Science 257: 789-792, 1992.
41. Lieber, A., C. Y. He, I. Kirillova, and M. A. Kay. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70: 8944-8960, 1996.
42. Lipkowitz, M. S., M. E. Klotman, J. Rappaport, B. Hanss, L. A. Bruggeman, P. A. Nicklin, and P. E. Klotman. Molecular therapy for renal diseases. Am. J. Kidney Dis. 28: 475-492, 1996.
43. Madsen, J. C., R. A. Superina, K. J. Wood, and P. J. Morris. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332: 161-164, 1988.
44. Mastrangeli, A., B.-G. Harvey, J. Yao, G. Wolff, I. Kovesdi, R. G. Crystal, and E. Falck-Pedersen. "Sero-switch" adenovirus-medicated In vivo gene transfer: circumvention of anti-adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7: 79-87, 1996.
45. Moore, K. J., T. Naito, C. Martin, and V. R. Kelley. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy. J. Immunol. 157: 433-440, 1996.
46. Moore, K. J., T. Wada, S. D. Barbee, and V. R. Kelley. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Faslpr mice. Kidney Int. In press.
47. Morishita, R., G. H. Gibbons, M. Horiuchi, K. E. Ellison, M. Nakama, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92: 5855-5859, 1995.
48. Moullier, P. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int. 45: 1220-1225, 1994.
49. Mulligan, R. C. The basic science of gene therapy. Science 260: 926-932, 1993.
50. Naffakh, N., A. Henri, J. L. Villeval, P. Rouyer-Fessard, P. Moullier, N. Blumenfeld, O. Danos, W. Vainchenker, J. M. Heard, and Y. Beuzard. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc. Natl. Acad. Sci. USA 92: 3194-3198, 1995.
51. Nagata, S. Apoptosis by death factor. Cell 88: 355-365, 1997.
52. Naito, T., H. Yokayama, K. J. Moore, G. Dranoff, R. C. Mulligan, and V. R. Kelley. A gene transfer system establishes interleukin-6 neither promotes nor suppresses renal injury. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F603-F609, 1996.
53. Naito, T., H. Yokoyama, K. J. Moore, G. Dranoff, R. C. Mulligan, and V. R. Kelley. Macrophage growth factors introduced into the kidney initiate renal injury. Mol. Med. 2: 297-312, 1996.
54. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. Gage, I. Verma, and D. Trono. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267, 1996.
55. Olthoff, K. M., T. A. Judge, A. E. Belman, S. Shen, W. W. Hancock, L. A. Turka, and A. Shaked. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat. Med. 2: 194-200, 1998.
56. Ory, D. S., B. A. Neugenboren, and R. C. Mulligan. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93: 11400-11406, 1996.
57. Pasqualini, R., and E. Ruoslahti. Organ targeting in vivo using phage display peptide libraries. Nature 380: 364-366, 1996.
58. Qin, L., K. D. Chavin, Y. Ding, J. E. Woodward, J. P. Favaro, J. Lin, and J. S. Bromberg. Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-β1. Ann. Surg. 220: 508-518, 1994.
59. Setoguchi, Y., C. Danel, and R. G. Crystal. Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector. Blood 84: 2946-2953, 1994.
60. Simons, J. W., E. M. Jaffee, C. E. Weber, H. I. Levitsky, W. G. Nelson, M. A. Carducci, A. J. Lazenby, L. K. Cohen, C. C. Finn, S. M. Clift, K. M. Hauda, L. A. Beck, K. M. Leiferman, A. H. J. Owens, S. Piantadosi, G. Dranoff, R. C. Mulligan, D. M. Pardoll, and F. F. Marshall. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 57: 1537-1546, 1997.
61. Sukhatme, V. P. Fibrosis. In: Transplantation Biology: Cellular and Molecular Aspects, edited by N. Tilney, T. Strom, and L. C. Paul. Philadelphia-New York: Lippincott-Raven, 1996, p. 249-255.
62. Sukhatme, V. P. Stenosis of vascular access revisited: pathobiology and prospects for prevention and therapy (Nephrology Forum). Kidney Int. 49: 1161-1174, 1996.
63. Sukhatme, V. P., B. D. Cowley, and G. Zhu. Gene transfer into kidney tubules and vasculature by adenoviral vectors. Exp. Nephrol. In press.
64. Tomita, N. Directed in vivo gene introduction into rat kidney. Biochem. Biophys. Res. Commun. 186: 129-134, 1992.
65. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2: 545-550, 1996.
66. Tripathy, S. K., E. C. Svensson, H. B. Black, E. Goldwasser, M. Margalith, P. M. Hobart, and J. M. Leiden. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA 93: 10876-10880, 1996.
67. Tryggvason, K., P. Heikkila, E. Pettersson, A. Tibell, and P. Thorner. Can Alport syndrome be treated by gene therapy? Kidney Int. 51: 1493-1499, 1997.
68. Wada, T., A. Schwarting, K. Kinoshita, T. Naito, R. C. Griffiths, T. M. Coffman, and V. R. Kelley. Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. Kidney Int. In press.
69. Yokoo, T., and M. Kitamura. Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector. Biochem. Biophys. Res. Commun. 226: 883-888, 1996.
70. Zeigler, S. T., J. D. Kerby, D. T. Curiel, A. G. Diethelm, and J. A. Thompson. Molecular conjugate-mediated gene transfer into isolated human kidneys. Transplantation 61: 812-817, 1996.
71. Zhu, G., A. G. Nicolson, B. Cowley, S. Rosen, and V. P. Sukhatme. In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther. 3: 298-304, 1996.
72. Zhu, G., A. G. Nicolson, X.-X. Zheng, T. B. Strom, and V. P. Sukhatme. Adenovirus-mediated β-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli. Kidney Int. 52: 992-999, 1997.